Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial-Reference-Cited by-同舟云学术

Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial

Published:2019-12 Issue:12 Volume:6 Page:e630-e637
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Ahmed Asra,Merrill Samuel A,Alsawah Fares,Bockenstedt Paula,Campagnaro Erica,Devata Sumana,Gitlin Scott D,Kaminski Mark,Cusick Alice,Phillips Tycel,Sood Suman,Talpaz Moshe,Quiery Albert,Boonstra Philip S,Wilcox Ryan A

Publisher

Elsevier BV

Subject

Hematology

Reference30 articles.

1. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment;Chandrakasan;J Pediatr,2013

2. How I treat hemophagocytic lymphohistiocytosis in the adult patient;Schram;Blood,2015

3. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation;Henter;Blood,2002

4. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study;Bergsten;Blood,2017

5. Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years;Schram;Br J Haematol,2016

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of JAK inhibitors in patients with adult-onset still's disease: A meta-analysis and systematic review;International Immunopharmacology;2024-08

2. Controlling HLH: dealing JAKs from the pack;Blood;2024-06-06

3. Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis;International Journal of Pharmaceutics;2024-05

4. Heterogeneity of macrophage activation syndrome and treatment progression;Frontiers in Immunology;2024-04-26

5. Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis;Blood Cancer Journal;2024-04-24